XML 44 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues (Tables)
12 Months Ended
Dec. 31, 2020
Revenues  
Schedule of disaggregated revenue

As discussed in Note 1, revenues are recognized under guidance within ASC 606 and ASC 808. The following table presents our disaggregated revenue for the periods presented (in thousands):

For the Years Ended,

    

December 31,

    

2020

2019

2018

JAKAFI revenues, net

$

1,937,850

$

1,684,968

$

1,386,964

ICLUSIG revenues, net

105,002

89,954

79,936

PEMAZYRE revenues, net

25,884

Total product revenues, net

2,068,736

1,774,922

1,466,900

JAKAVI product royalty revenues

277,902

225,913

194,694

OLUMIANT product royalty revenues

110,920

80,424

40,086

TABRECTA product royalty revenues

4,144

Total product royalty revenues

392,966

306,337

234,780

Milestone and contract revenues

205,000

77,500

180,000

Other revenues

203

Total revenues

$

2,666,702

$

2,158,759

$

1,881,883